FibroGen Stock (NASDAQ:FGEN), Quotes and News Summary

Q: What sector and industry does FibroGen (FGEN) operate in?

FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

FibroGen Stock (NASDAQ: FGEN) stock price, news, charts, stock research, profile.

Open	$1.160
Close	$1.150
Volume / Avg.	1.311M / 2.778M
Day Range	1.050 - 1.180
52 Wk Range	0.333 - 20.900
Market Cap	$112.599M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	6.91%
Days to Cover	3.3

Recent News

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.

Avi Kapoor

FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape

FibroGen reveals Phase 1 results for FG-3246 for metastatic castration-resistant prostate cancer. Promising efficacy metrics and plans for enhanced therapeutic strategies signal potential advancements in treatment. Learn more about this groundbreaking development."

Vandana Singh

Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones index closed higher by around 47 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

1.4

Strong Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

About FibroGen Inc

Sector

Health Care

Industry

Biotechnology

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing nove...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy FibroGen (FGEN) stock?

You can purchase shares of FibroGen (NASDAQ: FGEN) through any online brokerage.

View our list of the best stock brokerages.

Who are FibroGen's (FGEN) competitors?

Other companies in FibroGen’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX) and Cellectar Biosciences (NASDAQ:CLRB).

What is the target price for FibroGen (FGEN) stock?

The latest price target for FibroGen (NASDAQ: FGEN) was reported by B of A Securities on Tuesday, August 8, 2023. The analyst firm set a price target for 2.00 expecting FGEN to rise to within 12 months (a possible 75.44% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for FibroGen (FGEN)?

The stock price for FibroGen (NASDAQ: FGEN) is $1.14 last updated Today at April 19, 2024 at 5:30 PM EDT.

Does FibroGen (FGEN) pay a dividend?

There are no upcoming dividends for FibroGen.

When is FibroGen (NASDAQ:FGEN) reporting earnings?

FibroGen’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is FibroGen (FGEN) going to split?

There is no upcoming split for FibroGen.

What sector and industry does FibroGen (FGEN) operate in?

FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-